Plenamine Solution
Product Images NDC 0264-4500

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Plenamine (NDC 0264-4500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Plenamine Amino Acids Injection In Clinex 1)

Chemical structure diagram of phenylalanine, an amino acid component illustrated in the product Plenamine. The structure shows a benzyl side chain attached to the amino acid backbone, characteristic of phenylalanine.*

FDA Label Image

Recycle Symbol 7 Other (Plenamine Amino Acids Injection In Clinex 10)

Plenamine intravenous solution container with the proprietary name Plenamine and labeler B. Braun Medical Inc. The label displays the product name and indicates it is intended for intravenous use. The label includes cautionary symbols but does not specify the exact concentration or volume on the visible portion.*

FDA Label Image

1000 mL Container Label (Plenamine Amino Acids Injection In Clinex 11)

Plenamine 15% Amino Acids Injection 1000 mL intravenous solution labeled by B. Braun Medical Inc. The label specifies this is a pharmacy bulk package not for direct infusion, listing contents of essential and nonessential amino acids with their strengths. Storage instructions, lot, expiration details, and usage directions are also included, along with warnings against contamination and container damage.*

FDA Label Image

Entry Label (Plenamine Amino Acids Injection In Clinex 12)

A text panel titled with fields for recording the date and time of entry, as well as a space to note the number of hours after initial entry to discard the solution. The panel appears to be part of administration or usage instructions for proper handling of the Plenamine solution.*

FDA Label Image

Plenamine Amino Acids Injection In Clinex 13

Plenamine intravenous solution by B. Braun Medical Inc., in a clear glass vial with a silver metal cap and a gray rubber stopper, labeled with product name, strength, composition of multiple amino acids, and NDC 0264-4500. The label includes usage and manufacturing details in black text on a white background.*

FDA Label Image

Plenamine Amino Acids Injection In Clinex 14

Plenamine 15% Amino Acids Injection 2000 mL solution for intravenous use by B. Braun Medical Inc. The label lists essential and nonessential amino acid contents per 100 mL, storage instructions at 20 to 25°C, and usage directions for this pharmacy bulk package not for direct infusion. The product is sterile, single dose, and made in Germany.*

FDA Label Image

Chemical Structure (Plenamine Amino Acids Injection In Clinex 2)

Chemical structure diagram of L-tryptophan, showing an indole ring attached to a side chain with an amino group and a carboxylic acid group.*

FDA Label Image

Chemical Structure (Plenamine Amino Acids Injection In Clinex 3)

Chemical structure diagram of a molecule showing a five-membered ring with two nitrogen atoms connected to a side chain containing an amino group and a carboxylic acid group. This structure is consistent with the chemical depiction of histidine, an amino acid present in Plenamine solution.*

FDA Label Image

Chemical Structure (Plenamine Amino Acids Injection In Clinex 4)

Chemical structure diagram of the active ingredient proline, showing its molecular ring structure with attached functional groups.*

FDA Label Image

Chemical Structure (Plenamine Amino Acids Injection In Clinex 5)

Chemical structure diagram of the active ingredient Phenylalanine as shown in the product data for Plenamine solution by B. Braun Medical Inc.*

FDA Label Image

Step 1 Illustration (Plenamine Amino Acids Injection In Clinex 6)

An instructional diagram of a packaging wrap for a medical product showing labeled components: tear notches at the top, an oxygen absorber inside the packaging, and an oxygen indicator displayed nearby. The wrap includes an overlap at the top edge.*

FDA Label Image

Step 2 Figure 1 Illustration (Plenamine Amino Acids Injection In Clinex 7)

An instructional illustration showing hands demonstrating the removal or unfolding of a solution pouch from its packaging. One hand grips the top while the other pulls down, with an arrow indicating the direction of movement.*

FDA Label Image

Step 3 Figure 2 Illustration (Plenamine Amino Acids Injection In Clinex 8)

An instructional illustration showing a pair of hands holding a medical solution bag upright by the top, with the bag's two ports visible at the bottom. The image likely demonstrates preparation or handling of an intravenous solution bag for administration.*

FDA Label Image

Step 4 Figure 3 Illustration (Plenamine Amino Acids Injection In Clinex 9)

An instructional illustration comprising two panels labeled 3a and 3b. Panel 3a shows hands holding a flexible bag with one hand while pulling a protective cover from a port on the bag. Panel 3b depicts hands pushing a syringe or similar device into the exposed port on the bag, demonstrating how to access the contents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.